Peri-operative renal protection: The strategies revisited

Indian Journal of Urology

Volumn 28, Issue 3, 2012, Pages 248-255

  Bajwa, Sukhminder Jit Singh ^a   Sharma, Veenita ^a  

^a GIAN SAGAR MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Acute renal failure; acute tubular necrosis; nephrotoxins; peri operative renal protection strategies; renal protection

Indexed keywords

ACETYLCYSTEINE; ALBUMIN; ANARTIDE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CALCIUM; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; CORTICOSTEROID; DOPAMINE; ERYTHROPOIETIN; FENOLDOPAM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; LOOP DIURETIC AGENT; NATRIURETIC FACTOR; NESRITIDE; NITROPRUSSIDE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; OSMOTIC DIURETIC AGENT; SODIUM CHLORIDE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ABDOMINAL SURGERY; ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; CONTRAST INDUCED NEPHROPATHY; DIURETIC THERAPY; DRUG MECHANISM; FLUID THERAPY; HUMAN; HYPOVOLEMIA; INCIDENCE; NEPHROTOXICITY; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; RENAL PROTECTION; REVIEW; SURGICAL RISK; THORAX SURGERY;

EID: 84870221019     PISSN: 09701591     EISSN: 19983824     Source Type: Journal    
DOI: 10.4103/0970-1591.102691     Document Type: Review

References (60)

1. Mehta RL, Chertow GM. Acute renal failure definitions and classification: Time for change? J Am Soc Nephrol 2003;14:2178-87. (Pubitemid 36909928)
2. Stephen T. Webb J. Stephen D. Allen. Perioperative renal protection. Contin Educ Anaesth Crit Care Pain 2008;8:176-80.
3. Tian J, Barrantes F, Amoateng-Adjepong Y, Manthous CA. Rapid Reversal of Acute Kidney Injury and Hospital Outcomes: A Retrospective Cohort Study. Am J Kidney Dis 2009;53:974-81.
4. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12.
5. Jarnberg PO. Renal protection strategies in the perioperative period. Best Pract Res Clin Anaesthesiol 2004;18:645-60.
6. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005;365:417.
7. Dworkin LD. Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens 2001;10:551-3. (Pubitemid 32783801)
8. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubuleinjury. Kidney Int 2002;62:237-44. (Pubitemid 34754067)
9. Perco P, Oberbauer R. Kidney injury molecule-1 as a biomarker of acute kidney injury in renal transplant recipients. Nat Clin Pract Nephrol 2008;4:362-3. (Pubitemid 351913691)
10. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 Is an Early Diagnostic Marker for Acute Kidney Injury and Predicts Mortality in the Intensive Care Unit. J Am Soc Nephrol 2005;16:3046-52. (Pubitemid 44743502)
11. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231-8. (Pubitemid 40469655)
12. Himmelfarb J, Joannidis M, Molitoris B, Schietz M, Okusa MD, Warnock D, et al. Evaluation and initial management of acute kidney injury. Clin J Am Soc Nephrol 2008;3:962-7.
13. Carmichael P, Carmichael AR. Acute renal failure in the surgical setting. ANZ J Surg 2003;73:144-53. (Pubitemid 36513101)
14. Vincent JL, Gerlach H. Fluid resuscitation in severe sepsis and septic shock: An evidence-based review. Crit Care Med 2004;32(11 Suppl):S451-4. (Pubitemid 39489020)
15. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003;93:C29-34.
16. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-56. (Pubitemid 38669207)
17. Boldt J, Brosch C, Ducke M, Papsdorf M, Lehmann A. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: A comparison with human albumin. Crit Care Med 2007;35:2740-6. (Pubitemid 350175770)
18. Weisbord SD, Palevsky PM. Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol 2008;3:273-80.
19. Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, et al. Renal insufficiency following contrast media administration trial (REMEDIAL): A randomized comparison of 3 preventive strategies. Circulation 2007;115:1211-7. (Pubitemid 46594764)
20. Recio-Mayoral A, Chaparro M, Prado B, Cózar R, Méndez I, Banerjee D, et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: The RENO Study. J Am Coll Cardiol 2007;49:1283-8. (Pubitemid 46467227)
21. Aronson S, Blumenthal R. Perioperative renal dysfunction and cardiovascular anesthesia: Concerns and controversies. J Cardiothorac Vasc Anesth 1998;12:567-86. (Pubitemid 28473821)
22. Bellomo R, Auriemma S, Fabbri A, D'Onofrio A, Katz N, McCullough PA, et al. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs 2008;31:166-78. (Pubitemid 351425014)
23. Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med 2007;357:797-805.
24. Lameire N, Biesen WV, Hoste E, Vanholder R. The prevention of acute kidney injury: An in-depth narrative review Part 1: Volume resuscitation and avoidance of drug-and nephrotoxin-induced AKI. NDT Plus 2008;1:392-402.
25. Sarubbi FA Jr, Hull JH. Amikacin serum concentrations: Prediction of levels and dosage guidelines-Ann Intern Med 1978;89:612-8. (Pubitemid 9020976)
26. Bajwa SJ, Kwatra I. Reno-endocrinal disorders: A basic understanding of the molecular genetics. Indian J Endocr Metab 2012;16:158-63
27. De Laet I, Malbrain ML, Jadoul JL, Rogiers P, Sugrue M. Renal implications of increased intra-abdominal pressure: Are the kidneys the canary for abdominal hypertension? Acta Clin Belg Suppl 2007;1:119-30. (Pubitemid 46521981)
28. Bonventre JV. Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 2002;11:43-8. (Pubitemid 34053337)
29. Wijeysundera DN, Beattie WS, Djaiani G, Rao V, Borger MA, Karkouti K, et al. Off-pump coronary artery surgery for reducing mortality and morbidity: Meta-analysis of randomized and observational studies. J Am Coll Cardiol 2005;46:872-82. (Pubitemid 41224813)
30. Bown MJ, Norwood MG, Sayers RD. The management of abdominal aortic aneurysms in patients with concurrent renal impairment. Eur J Vasc Endovasc Surg 2005;30:1-11. (Pubitemid 40775126)
31. Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999;55:2423-32. (Pubitemid 29256497)
32. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000;356:2139-43.
33. Kellum JA. Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 2001;29:1526-31. (Pubitemid 32762331)
34. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: Low dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005;142:510-24.
35. Padmanabhan R. Renal dose dopamine-it's myth and the truth. J Assoc Physicians India 2002;50:571-5.
36. Weldon BC, Monk TG. The patient at risk for acute renal failure. Recognition, prevention, and preoperative optimization. Anesthesiol Clin North Am 2000;18:705-17.
37. Halpenny M, Lakshmi S, O'Donnell A, O'Callaghan-Enright S, Shorten GD. Fenoldopam: Renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia 2001;56:953-60. (Pubitemid 34023656)
38. Cogliati AA, Vellutini R, Nardini A, Urovi S, Hamdan M, Landoni G, et al. Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: A randomized clinical study. J Cardiothorac Vasc Anesth 2007;21:847-50. (Pubitemid 350192281)
39. Bagshaw SM, Ghali WA. Theophylline for prevention of contrastinduced nephropathy: A systematic review and meta-analysis. Arch Intern Med 2005;165:1087-93. (Pubitemid 40720732)
40. Rodicio JL, Campo C, Ruilope LM. Renal effects of calcium antagonists. Nephrol Dial Transplant 1995;10(Suppl 9):17-22.
41. Bagshaw SM, Delaney A, Haase M, Ghali WA, Bellomo R. Loop diuretics in the management of acute renal failure: A systematic review and metaanalysis. Crit Care Resusc 2007;9:60-8.
42. Bagshaw SM, Delaney A, Jones D, Ronco C, Bellomo R. Diuretics in themanagement of acute kidney injury: A multinational survey. Contrib Nephrol 2007;156:236-49.
43. Lameire N, Biesen WV, Hoste E, Vanholder R. The prevention of acute kidney injury an in-depth narrative review: Part 2: Drugs in the prevention of acute kidney injury-NDT Plus 2009;2:1-10.
44. Townsend DR, Bagshaw SM. New insights on intravenous fluids, diuretics and acute kidney injury. Nephron Clin Pract 2008;109:c106-16.
45. Uchino S, Doig GS, Bellomo R, Morimatsu H, Morgera S, Schetz M, et al. Diuretics and mortality in acute renal failure. Crit Care Med 2004;32:1669-77. (Pubitemid 39050516)
46. Bajwa SJ, Kulshrestha A. Renal endocrine manifestations during polytrauma: A cause of concern for the anesthesiologist. Indian J Endocr Metab 2012;16:252-7
47. Sever MS, Vanholder R, Lameire N. Management of crushrelated injuries after disasters. N Engl J Med 2006;354:1052-63.
48. Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol 2000;11:1553-61. (Pubitemid 30483474)
49. Reddy VG. Prevention of postoperative acute renal failure-J Postgrad Med 2002;48:64-70. (Pubitemid 34778026)
50. Schnuelle P, Van Der Woude JF. Perioperative fluid management in renal transplantation: A narrative review of the literature. Transpl Int 2006;19:947-59. (Pubitemid 44684114)
51. Vesely DL. Natriuretic peptides and acute renal failure. Am J Physiol Renal Physiol 2003;285:F167-77. (Pubitemid 36871189)
52. Lewis J, Salem MM, Chertow GM, Weisberg LS, McGrew F, Marbury TC, et al. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 2000;36:767-74.
53. Mentzer RM Jr, Oz MC, Sladen RN, Graeve AH, Hebeler RF Jr, Luber JM Jr, et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: The NAPA Trial. J Am Coll Cardiol 2007;49:716-26. (Pubitemid 46205038)
54. Clark LC, Farghaly H, Saba SR, Vesely DL. Amelioration with vessel dilator of acute tubular necrosis and renal failure established for 2 days. American Journal of Physiology. Heart Circ Physiol 2000;278:H1555-64. (Pubitemid 30395566)
55. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008;51:1419-28. (Pubitemid 351471786)
56. Birck R, Krzossok S, Markowetz F, Schnülle P, Van Der Woude FJ, Braun C. Acetylcysteine for prevention of contrast nephropathy: Metaanalysis. Lancet 2003;362:598-603. (Pubitemid 37013299)
57. Hoffmann U, Fischereder M, Krüger B, Drobnik W, Krämer BK. The value of Nacetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004;15:407-10. (Pubitemid 38140781)
58. Khanal S, Attallah N, Smith DE, Kline-Rogers E, Share D, O'Donnell MJ, et al. Statin therapy reduces contrastinduced nephropathy: An analysis of contemporary percutaneous interventions. Am J Med 2005;118:843-9. (Pubitemid 41097461)
59. Sturiale A, Campo S, Crascì E, Aloisi C, Buemi M. Experimental models of acute renal failure and erythropoietin: What evidence of a direct effect? Ren Fail 2007;29:379-86. (Pubitemid 46752342)
60. Veys N, Van BW, Lameire N. Internal medicine, renal anaemia, and erythropoiesis-stimulating agents (ESAS). Acta Clin Belg 2007;62:396-407. (Pubitemid 351236174)